News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
172,213 Results
Type
Article (8059)
Company Profile (121)
Press Release (164033)
Section
Business (57493)
Career Advice (263)
Deals (9945)
Drug Delivery (19)
Drug Development (22499)
Employer Resources (22)
FDA (4163)
Job Trends (4571)
News (92085)
Policy (6548)
Tag
Academia (598)
Accelerated approval (5)
Adcomms (4)
Allergies (41)
Alliances (8760)
ALS (25)
Alzheimer's disease (458)
Antibody-drug conjugate (ADC) (57)
Approvals (4292)
Artificial intelligence (92)
Autoimmune disease (26)
Automation (10)
Bankruptcy (50)
Best Places to Work (3759)
BIOSECURE Act (5)
Biosimilars (34)
Biotechnology (73)
Bladder cancer (50)
Brain cancer (11)
Breast cancer (197)
Cancer (1301)
Cardiovascular disease (117)
Career advice (234)
Career pathing (4)
CAR-T (59)
CDC (6)
Cell therapy (174)
Cervical cancer (14)
Clinical research (20382)
Collaboration (270)
Compensation (160)
Complete response letters (11)
COVID-19 (674)
CRISPR (19)
C-suite (62)
Cystic fibrosis (31)
Data (1886)
Depression (23)
Diabetes (130)
Diagnostics (1746)
Digital health (9)
Diversity, equity & inclusion (7)
Drug discovery (50)
Drug pricing (26)
Drug shortages (6)
Duchenne muscular dystrophy (49)
Earnings (41706)
Editorial (11)
Employer branding (2)
Employer resources (22)
Events (26435)
Executive appointments (119)
FDA (5035)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (238)
Gene editing (43)
Generative AI (6)
Gene therapy (148)
GLP-1 (268)
Government (1036)
Grass and pollen (3)
Guidances (307)
Healthcare (5407)
HIV (16)
Huntington's disease (14)
IgA nephropathy (35)
Immunology and inflammation (66)
Immuno-oncology (4)
Indications (21)
Infectious disease (736)
Inflammatory bowel disease (38)
Inflation Reduction Act (1)
Influenza (26)
Intellectual property (40)
Interviews (27)
IPO (6072)
IRA (5)
Job creations (1006)
Job search strategy (214)
Kidney cancer (5)
Labor market (22)
Layoffs (141)
Leadership (3)
Legal (1126)
Liver cancer (19)
Longevity (3)
Lung cancer (219)
Lymphoma (114)
Machine learning (6)
Management (6)
Manufacturing (150)
MASH (44)
Medical device (3566)
Medtech (3576)
Mergers & acquisitions (4197)
Metabolic disorders (312)
Multiple sclerosis (50)
NASH (5)
Neurodegenerative disease (52)
Neuropsychiatric disorders (14)
Neuroscience (729)
NextGen: Class of 2025 (1618)
Non-profit (1097)
Now hiring (16)
Obesity (134)
Opinion (35)
Ovarian cancer (44)
Pain (44)
Pancreatic cancer (50)
Parkinson's disease (66)
Partnered (9)
Patents (83)
Patient recruitment (83)
Peanut (15)
People (7672)
Pharmaceutical (31)
Pharmacy benefit managers (5)
Phase I (5251)
Phase II (8862)
Phase III (7844)
Pipeline (1720)
Policy (31)
Postmarket research (741)
Preclinical (1645)
Press Release (21)
Prostate cancer (60)
Psychedelics (12)
Radiopharmaceuticals (42)
Rare diseases (184)
Real estate (1255)
Recruiting (11)
Regulatory (5272)
Reports (16)
Research institute (566)
Resumes & cover letters (25)
Rett syndrome (14)
RNA editing (4)
RSV (12)
Schizophrenia (47)
Series A (32)
Series B (25)
Service/supplier (2)
Sickle cell disease (23)
Special edition (8)
Spinal muscular atrophy (44)
Sponsored (10)
Startups (662)
Stomach cancer (5)
Supply chain (19)
Tariffs (20)
The Weekly (5)
Vaccines (225)
Venture capital (18)
Weight loss (89)
Women's health (17)
Worklife (3)
Date
Today (47)
Last 7 days (297)
Last 30 days (1414)
Last 365 days (9483)
2025 (8665)
2024 (10448)
2023 (11613)
2022 (14906)
2021 (15943)
2020 (14822)
2019 (12472)
2018 (9381)
2017 (8561)
2016 (7840)
2015 (9227)
2014 (6215)
2013 (4298)
2012 (4974)
2011 (5418)
2010 (4452)
Location
Africa (162)
Alabama (17)
Arizona (52)
Arkansas (1)
Asia (10088)
Australia (1788)
California (3025)
Canada (801)
China (246)
Colorado (124)
Connecticut (101)
Delaware (114)
Europe (24667)
Florida (428)
Georgia (103)
Idaho (11)
Illinois (206)
India (13)
Indiana (151)
Iowa (5)
Japan (122)
Kansas (28)
Kentucky (10)
Louisiana (14)
Maine (14)
Maryland (394)
Massachusetts (2164)
Michigan (71)
Minnesota (207)
Mississippi (4)
Missouri (29)
Montana (15)
Nebraska (3)
Nevada (47)
New Hampshire (30)
New Jersey (1104)
New Mexico (4)
New York (809)
North Carolina (393)
Northern California (1468)
Ohio (74)
Oklahoma (7)
Oregon (8)
Pennsylvania (568)
Rhode Island (14)
South America (298)
South Carolina (4)
South Dakota (1)
Southern California (1209)
Tennessee (28)
Texas (421)
United States (10825)
Utah (89)
Virginia (40)
Washington D.C. (18)
Washington State (250)
West Virginia (1)
Wisconsin (36)
172,213 Results for "40".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioSpace
Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
The inaugural 40 Under 40 cohort includes CEOs, leaders who have founded or co-founded their company and executives from a range of disciplines. Winners’ accomplishments include shaping drug development, achieving key FDA milestones and launching a new field of study.
October 7, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0
November 7, 2025
·
7 min read
Press Releases
Life Science Market Size Worth USD 278.40 Billion by 2034
November 5, 2025
·
1 min read
Press Releases
ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM
November 7, 2025
·
2 min read
Autoimmune disease
Biogen Seeks To Stand Out in Lupus With New Anti-CD40L Data
Phase III data for dapirolizumab pegol presented at the 2025 conference of the American College of Rheumatology showed quality-of-life benefits in systemic lupus erythematosus that could see Biogen go head-to-head with GSK and AstraZeneca in a blockbuster space.
October 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
November 6, 2025
·
5 min read
Press Releases
Curve Biosciences Raises $40 Million to Bring Whole-Body Intelligence to Chronic Disease Monitoring
October 30, 2025
·
3 min read
Press Releases
Alligator Bioscience Presents New Data on Mitazalimab and ATOR-4066 at SITC 40th Anniversary Annual Meeting
November 5, 2025
·
3 min read
Press Releases
Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
October 17, 2025
·
6 min read
Press Releases
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 10, 2025
·
14 min read
1 of 17,222
Next
